FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:1539-1550 October 12, 2006 Number 15 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Supplementary Material Editorial by Iseman, M. D. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background New diagnostic tools are urgently needed to interrupt the transmission of tuberculosis and multidrug-resistant tuberculosis. Rapid, sensitive detection of tuberculosis and multidrug-resistant tuberculosis in sputum has been demonstrated in proof-of-principle studies of the microscopic-observation drug-susceptibility (MODS) assay, in which broth cultures are examined microscopically to detect characteristic growth.

Methods In an operational setting in Peru, we investigated the performance of the MODS assay for culture and drug-susceptibility testing in three target groups: unselected patients with suspected tuberculosis, prescreened patients at high risk for tuberculosis or multidrug-resistant tuberculosis, and unselected hospitalized patients infected with the human immunodeficiency virus. We compared the MODS assay head-to-head with two reference methods: automated mycobacterial culture and culture on Löwenstein–Jensen medium with the proportion method.

Results Of 3760 sputum samples, 401 (10.7%) yielded cultures positive for Mycobacterium tuberculosis. Sensitivity of detection was 97.8% for MODS culture, 89.0% for automated mycobacterial culture, and 84.0% for Löwenstein–Jensen culture (P<0.001); the median time to culture positivity was 7 days, 13 days, and 26 days, respectively (P<0.001), and the median time to the results of susceptibility tests was 7 days, 22 days, and 68 days, respectively. The incremental benefit of a second MODS culture was minimal, particularly in patients at high risk for tuberculosis or multidrug-resistant tuberculosis. Agreement between MODS and the reference standard for susceptibility was 100% for rifampin, 97% for isoniazid, 99% for rifampin and isoniazid (combined results for multidrug resistance), 95% for ethambutol, and 92% for streptomycin (kappa values, 1.0, 0.89, 0.93, 0.71, and 0.72, respectively).

Conclusions A single MODS culture of a sputum sample offers more rapid and sensitive detection of tuberculosis and multidrug-resistant tuberculosis than the existing gold-standard methods used.

Source Information

From the Department of Infectious Diseases and Immunity and the Wellcome Centre for Clinical Tropical Medicine, Imperial College London, Faculty of Medicine (Hammersmith Campus), London (D.A.J.M., C.A.W.E., A.R.E., J.S.F.); Asociación Benéfica PRISMA, San Miguel (D.A.J.M., C.A.W.E., R.H.G., M.-G.H.-D., A.R.E.), Laboratorio de Investigación de Enfermedades Infecciosas, Universidad Peruana Cayetano Heredia, San Martín de Porras (D.A.J.M., C.A.W.E., R.H.G., L.C., J.C., A.R.E.), Hospital Nacional General Arzobispo Loayza (A.V., Y.P.), Hospital Nacional Hipolito Unanue, El Agustino (E.S.), Dirección de Salud–III Lima Norte (Ministerio de Salud), Rimac (J.C.S.), and Dirección de Salud–IV Lima Este (Ministerio de Salud), El Agustino (C.S., D.L.) — all in Lima, Peru; the Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore (D.A.J.M., C.A.W.E., R.H.G.); and the Tulane School of Public Health and Tropical Medicine, New Orleans (R.O.).

Address reprint requests to Dr. Moore at the Department of Infectious Diseases and Immunity and Wellcome Centre for Clinical Tropical Medicine, Imperial College London, Faculty of Medicine (Hammersmith Campus), DuCane Rd., London W12 0NN, United Kingdom, or at davidajmoore{at}msn.com.

Full Text of this Article

Related Letters:

MODS Assay for the Diagnosis of TB
Palomino J.-C., Martin A., Portaels F., Hasan R., Irfan S., Moore D. A.J., Gilman R. H., Friedland J. S.
Extract | Full Text | PDF  
N Engl J Med 2007; 356:188-189, Jan 11, 2007. Correspondence

This article has been cited by other articles:

• Perlman, D. C., Leung, C. C., Yew, W. W. (2009). Diagnosing Tuberculosis in Patients with HIV: Do We Know Enough?. Am. J. Respir. Crit. Care Med. 180: 800-801 [Full Text]  
• Sheen, P., Mendez, M., Gilman, R. H., Pena, L., Caviedes, L., Zimic, M. J., Zhang, Y., Moore, D. A. J., Evans, C. A. (2009). Sputum PCR-Single-Strand Conformational Polymorphism Test for Same-Day Detection of Pyrazinamide Resistance in Tuberculosis Patients. J. Clin. Microbiol. 47: 2937-2943 [Abstract] [Full Text]  
• Schluger, N. W. (2009). Drug-Resistant Tuberculosis: What Is To Be Done?. Chest 136: 333-335 [Full Text]  
• Wilson, D., Hurtado, R. M., Digumarthy, S. (2009). Case 18-2009 -- A 24-Year-Old Woman with AIDS and Tuberculosis with Progressive Cough, Dyspnea, and Wasting. NEJM 360: 2456-2464 [Full Text]  
• Devasia, R. A., Blackman, A., May, C., Eden, S., Smith, T., Hooper, N., Maruri, F., Stratton, C., Shintani, A., Sterling, T. R. (2009). Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance. J Antimicrob Chemother 63: 1173-1178 [Abstract] [Full Text]  
• Basu, S., Friedland, G. H., Medlock, J., Andrews, J. R., Shah, N. S., Gandhi, N. R., Moll, A., Moodley, P., Sturm, A. W., Galvani, A. P. (2009). Averting epidemics of extensively drug-resistant tuberculosis. Proc. Natl. Acad. Sci. USA 106: 7672-7677 [Abstract] [Full Text]  
• Wolf, H., Mendez, M., Gilman, R. H., Sheen, P., Soto, G., Velarde, A. K., Zimic, M., Escombe, A. R., Montenegro, S., Oberhelman, R. A., Evans, C. A. (2008). Diagnosis of Pediatric Pulmonary Tuberculosis by Stool PCR. Am J Trop Med Hyg 79: 893-898 [Abstract] [Full Text]  
• Leonard, B., Coronel, J., Siedner, M., Grandjean, L., Caviedes, L., Navarro, P., Gilman, R. H., Moore, D. A. J. (2008). Inter- and Intra-Assay Reproducibility of Microplate Alamar Blue Assay Results for Isoniazid, Rifampicin, Ethambutol, Streptomycin, Ciprofloxacin, and Capreomycin Drug Susceptibility Testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 46: 3526-3529 [Abstract] [Full Text]  
• Rojas, C., Solari, L., Herrera, C., Sanchez, E., Young, G., Bonilla, C., Hurtado, R., Munoz, M., Zeladita, J., Espiritu, B., Shin, S. (2008). Challenges of Diagnosis and Management of Tuberculosis and HIV Coinfection in Resource-Limited Settings: A Case Report from Lima, Peru. J Int Assoc Physicians AIDS Care (Chic Ill) 7: 232-237 [Abstract]  
• Grant, A., Gothard, P., Thwaites, G. (2008). Managing drug resistant tuberculosis. BMJ 337: a1110-a1110 [Full Text]  
• Grandjean, L., Martin, L., Gilman, R. H., Valencia, T., Herrera, B., Quino, W., Ramos, E., Rivero, M., Montoya, R., Escombe, A. R., Coleman, D., Mitchison, D., Evans, C. A. (2008). Tuberculosis Diagnosis and Multidrug Resistance Testing by Direct Sputum Culture in Selective Broth without Decontamination or Centrifugation. J. Clin. Microbiol. 46: 2339-2344 [Abstract] [Full Text]  
• Moore-Gillon, J. C (2007). Tuberculosis and its future management. Thorax 62: 1019-1021 [Full Text]  
• Mello, F. C. Q., Arias, M. S., Rosales, S., Marsico, A. G., Pavon, A., Alvarado-Galvez, C., Pessoa, C. L. C., Perez, M., Andrade, M. K., Kritski, A. L., Fonseca, L. S., Chaisson, R. E., Kimerling, M. E., Dorman, S. E. (2007). Clinical Evaluation of the Microscopic Observation Drug Susceptibility Assay for Detection of Mycobacterium tuberculosis Resistance to Isoniazid or Rifampin. J. Clin. Microbiol. 45: 3387-3389 [Abstract] [Full Text]  
• Munir, T. (2007). Microscopic observation drug susceptibility assay for the diagnosis of TB. Thorax 62: 847-847 [Full Text]  
• Mendelson, M. (2007). Diagnosing tuberculosis in HIV-infected patients: challenges and future prospects. Br Med Bull 0: ldm009v1-17 [Abstract] [Full Text]  
• (2007). ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB. Evid. Based Med. 12: 62-62 [Full Text]  
• Shiferaw, G., Woldeamanuel, Y., Gebeyehu, M., Girmachew, F., Demessie, D., Lemma, E. (2007). Evaluation of Microscopic Observation Drug Susceptibility Assay for Detection of Multidrug-Resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 45: 1093-1097 [Abstract] [Full Text]  
• Palomino, J.-C., Martin, A., Portaels, F., Hasan, R., Irfan, S., Moore, D. A.J., Gilman, R. H., Friedland, J. S. (2007). MODS Assay for the Diagnosis of TB. NEJM 356: 188-189 [Full Text]  
• Iseman, M. D., Heifets, L. B. (2006). Rapid detection of tuberculosis and drug-resistant tuberculosis.. NEJM 355: 1606-1608 [Full Text]  
• (2006). Faster Diagnosis of MDR-TB. JWatch Infect. Diseases 2006: 1-1 [Full Text]